Viatris VTRS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Viatris (VTRS) Business Model and Operations Summary
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Key Insights
Viatris (VTRS) Core Market Data and Business Metrics
Latest Closing Price
$8.6Market Cap
$10.25 BillionPrice-Earnings Ratio
53.75Total Outstanding Shares
1.19 Billion SharesTotal Employees
32,000Dividend
$0.12 Per Share QuarterlyIPO Date
April 14, 1986SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
1000 Mylan Boulevard, Canonsburg, PA, 15317
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $937.70 Million |
| Net Cash Flow From Operating Activities | $826.50 Million |
| Net Cash Flow From Investing Activities, Continuing | $1.75 Billion |
| Net Cash Flow From Operating Activities, Continuing | $826.50 Million |
| Net Cash Flow From Investing Activities | $1.75 Billion |
| Net Cash Flow | $961.60 Million |
Income Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $3.66 Billion |
| Income Tax Expense/Benefit | $-4.30 Million |
| Common Stock Dividends | $0.12 |
| Costs And Expenses | $3.66 Billion |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Gross Profit | $1.46 Billion |
Comprehensive Income
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $383.70 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $288.90 Million |
| Comprehensive Income/Loss | $383.70 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $33.45 Billion |
| Equity Attributable To Noncontrolling Interest | $0 |
| Equity | $19.79 Billion |
| Wages | $668.20 Million |
| Inventory | $4.08 Billion |
| Prepaid Expenses | $134.50 Million |
Historical Dividends
Current dividend: $0.12 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 27, 2025 | Mar 18, 2025 | Mar 10, 2025 | $0.12 | Quarterly |
| Nov 4, 2024 | Dec 13, 2024 | Nov 22, 2024 | $0.12 | Quarterly |
| Aug 5, 2024 | Sep 13, 2024 | Aug 23, 2024 | $0.12 | Quarterly |
| May 6, 2024 | Jun 14, 2024 | May 24, 2024 | $0.12 | Quarterly |
| Feb 26, 2024 | Mar 18, 2024 | Mar 11, 2024 | $0.12 | Quarterly |
| Nov 7, 2023 | Dec 15, 2023 | Nov 24, 2023 | $0.12 | Quarterly |